{"id":"https://openalex.org/W1676011408","doi":"https://doi.org/10.4049/jimmunol.158.8.3787","title":"Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines","display_name":"Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines","alternate_titles":[],"publication_year":1997,"publication_date":"1997-04-01","ids":{"openalex":"https://openalex.org/W1676011408","doi":"https://doi.org/10.4049/jimmunol.158.8.3787","mag":"1676011408","pmid":"https://pubmed.ncbi.nlm.nih.gov/9103444"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.158.8.3787","doi":"https://doi.org/10.4049/jimmunol.158.8.3787","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.158.8.3787","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1676011408"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"E Dufour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E Dufour","raw_affiliation_strings":["INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070904480","display_name":"Guislaine Carcelain","orcid":"https://orcid.org/0000-0002-3192-3858","observed_orcids":["https://orcid.org/0000-0002-3192-3858"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Carcelain","raw_affiliation_strings":["INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111712781","display_name":"Catherine Gaudin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Gaudin","raw_affiliation_strings":["INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000473619","display_name":"Caroline Flament","orcid":"https://orcid.org/0000-0003-2584-3488","observed_orcids":["https://orcid.org/0000-0003-2584-3488"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Flament","raw_affiliation_strings":["INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112016914","display_name":"M.-F. Avril","orcid":"https://orcid.org/0000-0002-9112-8477","observed_orcids":["https://orcid.org/0000-0002-9112-8477"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M F Avril","raw_affiliation_strings":["INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066797001","display_name":"Florence Faure","orcid":"https://orcid.org/0000-0002-8359-4283","observed_orcids":["https://orcid.org/0000-0002-8359-4283"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Faure","raw_affiliation_strings":["INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 333, Gustave Roussy Institute (IGR), Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":1.0465,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.74827931,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"158","issue":"8","first_page":"3787","last_page":"3795"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9365000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9365000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.025800000876188278,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-specific-immunity","display_name":"tumor-specific immunity","score":0.7250000238418579},{"id":"https://openalex.org/keywords/ctl-clones","display_name":"CTL clones","score":0.5379999876022339},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.8790000081062317},{"id":"https://openalex.org/keywords/autologous-tumor-cells","display_name":"autologous tumor cells","score":0.7369999885559082},{"id":"https://openalex.org/keywords/cancer-cell-lines","display_name":"cancer cell lines","score":0.7059999704360962},{"id":"https://openalex.org/keywords/hla-a2","display_name":"HLA-A2","score":0.8410000205039978},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.8019999861717224},{"id":"https://openalex.org/keywords/mhc-class-i-restriction","display_name":"MHC class I restriction","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-rejection","display_name":"tumor rejection","score":0.7289999723434448},{"id":"https://openalex.org/keywords/lymph-nodes","display_name":"lymph nodes","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.8827203512191772},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6985108256340027},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6190487742424011},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6117048263549805},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6042580008506775},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5828859806060791},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.49628502130508423},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.4731218218803406},{"id":"https://openalex.org/C81089528","wikidata":"https://www.wikidata.org/wiki/Q5134986","display_name":"clone (Java method)","level":3,"score":0.44517430663108826},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.43567758798599243},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4321228265762329},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.42713651061058044},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4152003228664398},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41500696539878845},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4103318750858307},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06639429926872253},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0487426221370697},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002999","descriptor_name":"Clone Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4049/jimmunol.158.8.3787","doi":"https://doi.org/10.4049/jimmunol.158.8.3787","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.158.8.3787","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:9103444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9103444","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990160877","https://openalex.org/W1831952690","https://openalex.org/W2123589562","https://openalex.org/W2067615306","https://openalex.org/W1989448180","https://openalex.org/W2142647027","https://openalex.org/W2054639395","https://openalex.org/W1977305815","https://openalex.org/W2147266039","https://openalex.org/W1992422016"],"abstract_inverted_index":{"In":[0],"the":[1,6,9,24,58,66,90,116,123,137,164,228,240],"present":[2],"work,":[3],"to":[4,77],"analyze":[5],"heterogeneity":[7],"of":[8,17,26,35,44,57,65,97,103,136,163,181],"tumor-specific":[10,104],"cytotoxic":[11],"immune":[12,229,243],"response,":[13],"a":[14,27,49,54,79,129,219],"large":[15],"number":[16],"T":[18,45,155],"cell":[19,46,61,111,119,214,234],"clones":[20,39,47,141,184],"were":[21,40],"generated":[22],"from":[23],"infiltrate":[25],"tumor-proximal":[28],"invaded":[29],"lymph":[30],"node,":[31],"and":[32,71,108,157,168],"two":[33,138],"kinds":[34],"melanoma-specific":[36,199],"CD8+":[37],"CTL":[38,105,140,183],"derived.":[41],"The":[42,100],"majority":[43],"(about":[48],"hundred)":[50],"are":[51],"characterized":[52],"by":[53],"specific":[55],"lysis":[56],"autologous":[59,117,125,151],"tumor":[60,83,91,126,213,222],"lines.":[62],"Among":[63],"34":[64],"latter":[67],"clones,":[68],"HLA-A2":[69],"molecule":[70],"MART-1(27-35)":[72],"peptide":[73],"have":[74,142,204],"been":[75,205],"shown":[76,143,178],"play":[78,218],"predominant":[80],"role":[81,220],"in":[82,128,221,241],"recognition.":[84],"However,":[85],"no":[86],"significant":[87],"amplification":[88],"at":[89],"site":[92],"was":[93,185],"observed":[94],"for":[95],"3":[96],"these":[98,182],"CTL.":[99],"other":[101],"kind":[102],"(1":[106],"oligoclonal":[107],"2":[109],"clonal":[110],"lines)":[112],"did":[113,146],"not":[114,147,194,203,237],"lyse":[115,148],"melanoma":[118,170,233],"lines":[120,235],"but":[121],"lysed":[122],"\"fresh\"":[124],"cells":[127,160,171],"MHC":[130],"class":[131],"I-dependent":[132],"manner.":[133],"Functional":[134],"analysis":[135,176],"different":[139],"that":[144,179,227],"they":[145],"NK":[149],"targets,":[150],"peripheral":[152],"monocytes,":[153],"activated":[154],"cells,":[156],"transformed":[158],"B":[159],"or":[161],"any":[162],"few":[165],"allogeneic":[166],"cultured":[167],"uncultured":[169],"we":[172],"tested.":[173],"TCR":[174],"repertoire":[175],"has":[177],"one":[180],"significantly":[186],"detectable":[187,195],"\"in":[188],"situ\"":[189],"among":[190,196],"tumor-infiltrating":[191],"lymphocytes,":[192,200],"while":[193],"PBMC.":[197],"Such":[198],"which":[201],"could":[202,216],"picked":[206],"out":[207],"through":[208],"conventional":[209],"screening":[210],"procedures":[211],"using":[212],"lines,":[215],"potentially":[217],"rejection.":[223],"These":[224],"results":[225],"suggest":[226],"response":[230],"analyzed":[231],"toward":[232],"does":[236],"totally":[238],"reflect":[239],"situ":[242],"status.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1676011408","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
